Literature DB >> 2960695

Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

S Vora1, S DiMauro, D Spear, D Harker, M J Danon.   

Abstract

Human phosphofructokinase (PFK) exists in tetrameric isozymic forms, at least in vitro. Muscle and liver contain homotetramers M4 and L4, respectively, whereas red cells contain five isozymes composed of M (muscle) and L (liver) type subunits, i.e., M4, M3L, M2L2, and ML3, and L4. Homozygous deficiency of muscle PFK results in the classic glycogen storage disease type VII characterized by exertional myopathy and hemolytic syndrome beginning in early childhood. The genetic lesion results in a total and partial loss of muscle and red cell PFK, respectively. Characteristically, the residual red cell PFK from the patients consists of isolated L4 isozyme; the M-containing hybrid isozymes are completely absent. In this study, we investigated an 80-yr-old man who presented with a 10-yr history of progressive weakness of the lower limbs as the only symptom. The residual red cell PFK showed the presence of a few M-containing isozymes in addition to the predominant L4 species, indicating that the genetic lesion is a "leaky" mutation of the gene coding for the M subunit. The presence of a small amount of enzyme activity in the muscle may account for the atypical myopathy in this patient.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960695      PMCID: PMC442407          DOI: 10.1172/JCI113229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Studies on structure of human erythrocyte phosphofructokinase.

Authors:  N S Karadsheh; K Uyeda; R M Oliver
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

3.  Studies on the association behaviour of human-erythrocyte phosphofructokinase.

Authors:  G Zimmermann; K W Wenzel; J Gauer; E Hofmann
Journal:  Eur J Biochem       Date:  1973-12-17

4.  Aggregation of rabbit muscle phosphofructokinase.

Authors:  M J Pavelich; G G Hammes
Journal:  Biochemistry       Date:  1973-03-27       Impact factor: 3.162

5.  Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency.

Authors:  T Shimizu; M Kuwajima; N Kono; I Mineo; S Sumi; T Yonezawa; K Nonaka; S Tarui
Journal:  Med J Osaka Univ       Date:  1983-03

6.  A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expression.

Authors:  J Etiemble; J Simeon; H A Buc; C Picat; M Boulard; P Boivin
Journal:  Biochim Biophys Acta       Date:  1983-09-13

7.  Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

Authors:  S Vora; C Seaman; S Durham; S Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Rat liver phosphofructokinase: use of fluorescence polarization to study aggregation at low protein concentration.

Authors:  G D Reinhart; H A Lardy
Journal:  Biochemistry       Date:  1980-04-01       Impact factor: 3.162

9.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Urea and methylamine effects on rabbit muscle phosphofructokinase. Catalytic stability and aggregation state as a function of pH and temperature.

Authors:  S C Hand; G N Somero
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

View more
  7 in total

Review 1.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

Review 2.  Genetics of hyperuricemia and gout: implications for the present and future.

Authors:  Ronald L George; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

3.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

4.  Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.

Authors:  N Raben; R Exelbert; R Spiegel; J B Sherman; H Nakajima; P Plotz; J Heinisch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

5.  Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency.

Authors:  S Tsujino; S Servidei; P Tonin; S Shanske; G Azan; S DiMauro
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

Review 6.  The genetics of hyperuricaemia and gout.

Authors:  Anthony M Reginato; David B Mount; Irene Yang; Hyon K Choi
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

7.  251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands.

Authors:  Pascal Laforêt; Anders Oldfors; Edoardo Malfatti; John Vissing
Journal:  Neuromuscul Disord       Date:  2021-01-23       Impact factor: 4.296

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.